Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-25-002210
Filing Date
2025-04-02
Accepted
2025-04-02 13:43:25
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6349
  Complete submission text file 0001683168-25-002210.txt   7867
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Issuer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Mazar Andrew Paul (Reporting) CIK: 0001727393 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42139 | Film No.: 25803309